ELRIG Drug Discovery 2026 has ended. This guide stays up as the record of who was there. Next: ELRIG DD 2027, Oct 19–20, 2027 in Liverpool
Evotec at ELRIG Drug Discovery 2026
Oct 14–15, 2026 London, UK ~3k attendees Website
Evotec takes part in 2 sessions at ELRIG Drug Discovery 2026 in London, and exhibits at Booth C33. Its program spans toxicity prediction and biophysical hit finding. It covers a transcriptomics and AI framework for spotting kidney toxicity early, and biosensor screening of large lead-like chemical libraries in pools to find small-molecule hits.
| Organization | ELRIG Drug Discovery 2026 Attendance |
|---|---|
Evotec Hamburg, Germany | |
Drug discovery and development partner offering CRO and CDMO services, integrated programs and strategic partnerships from target to clinic. | Booth Exhibiting at Booth C33 Wed, Oct 148:00am–7:00pmThu, Oct 158:00am–4:00pm Talk Wed Oct 14 12:05pm–12:20pm A Transcriptomics‑AI Framework for Early Detection and De‑Risking of Nephrotoxicity How gene activity readouts combined with machine learning flagged kidney-damaging compounds early and pointed to the mechanisms behind the injury. Talk Wed Oct 14 4:15pm–4:30pm Biosensor based screening of large lead like chemical libraries in pools - an alternative biophysical approach for hit identification in small molecule drug discovery Screening large pools of lead-like compounds with surface plasmon resonance and related biosensors to find direct binders and measure their binding behaviour. |
Instantly find 20 buyers from Evotec
Get a list of who you should contact, their contact info, and what to say.
Totally free and instant, no sign up necessary!
Not affiliated with or endorsed by ELRIG. Submit a correction